The Oncology Institute, Inc.
TOI
$4.49
$0.030.67%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 13.15% | -48.57% | 18.19% | -4.10% | 22.17% |
| Total Depreciation and Amortization | 1.18% | 4.51% | 8.52% | 3.62% | 1.95% |
| Total Amortization of Deferred Charges | -76.84% | 205.77% | 0.44% | 1.41% | 0.38% |
| Total Other Non-Cash Items | 48.81% | 260.84% | -42.27% | 1,526.06% | -96.15% |
| Change in Net Operating Assets | -204.99% | -75.43% | 11.09% | 436.55% | -24.67% |
| Cash from Operations | -104.53% | -219.16% | 411.11% | 105.23% | 1.40% |
| Capital Expenditure | -268.29% | 81.31% | -536.57% | 122.02% | -199.34% |
| Sale of Property, Plant, and Equipment | -100.00% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -100.00% | -50.00% | 0.02% |
| Cash from Investing | -498.02% | 88.49% | -116.87% | -42.77% | -6.25% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 98.81% | -1,635.51% | -217.66% | 11,111.11% | 99.11% |
| Issuance of Common Stock | -85.78% | -- | -- | -100.00% | -97.26% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 181.20% | 42.34% | -- |
| Cash from Financing | 141.41% | -2,790.24% | 32.51% | 88.68% | -128.89% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.86% | -538.02% | -79.35% | 2,875.07% | -85.63% |